Literature DB >> 20471997

Macrophage HIV-1 infection in duodenal tissue of patients on long term HAART.

Alberto Zalar1, Maria Ines Figueroa, Beatriz Ruibal-Ares, Patricia Baré, Pedro Cahn, Maria Marta de E de Bracco, Liliana Belmonte.   

Abstract

Mucosal surfaces play a major role in human immunodeficiency virus type 1 (HIV-1) transmission and pathogenesis. Since the role of intestinal macrophages as viral reservoirs during chronic HIV-1 infection has not been elucidated, we investigated the effects of successful therapy on intestinal HIV-1 persistence. Intestinal macrophage infection was demonstrated by the expression of p24 antigen by flow cytometry and by the presence of proviral DNA, assessed by PCR. Proviral DNA was detected in duodenal mucosa of HIV-infected patients under treatment with undetectable plasma viral load. These findings confirm that intestinal macrophages can act as viral reservoirs and permit HIV-1 production even after viral suppression following antiretroviral therapy. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20471997     DOI: 10.1016/j.antiviral.2010.05.005

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  55 in total

Review 1.  Role of the macrophage in HIV-associated neurocognitive disorders and other comorbidities in patients on effective antiretroviral treatment.

Authors:  Jay Rappaport; David J Volsky
Journal:  J Neurovirol       Date:  2015-05-02       Impact factor: 2.643

2.  HIV-1 Alters Intestinal Expression of Drug Transporters and Metabolic Enzymes: Implications for Antiretroviral Drug Disposition.

Authors:  Olena Kis; Sumathi Sankaran-Walters; M Tozammel Hoque; Sharon L Walmsley; Satya Dandekar; Reina Bendayan
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

Review 3.  Potential implication of residual viremia in patients on effective antiretroviral therapy.

Authors:  Gautam K Sahu
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

Review 4.  Impact of Myeloid Reservoirs in HIV Cure Trials.

Authors:  Brooks I Mitchell; Elizabeth I Laws; Lishomwa C Ndhlovu
Journal:  Curr HIV/AIDS Rep       Date:  2019-04       Impact factor: 5.071

Review 5.  Changes in HIV reservoirs during long-term antiretroviral therapy.

Authors:  Feiyu F Hong; John W Mellors
Journal:  Curr Opin HIV AIDS       Date:  2015-01       Impact factor: 4.283

6.  A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruption.

Authors:  Viviane M Andrade; Carla Mavian; Dunja Babic; Thaissa Cordeiro; Mark Sharkey; Labelle Barrios; Christian Brander; Javier Martinez-Picado; Judith Dalmau; Anuska Llano; Jonathan Z Li; Jeffrey Jacobson; Christy L Lavine; Michael S Seaman; Marco Salemi; Mario Stevenson
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-16       Impact factor: 11.205

Review 7.  Gastrointestinal tract and the mucosal macrophage reservoir in HIV infection.

Authors:  Dallas Brown; Joseph J Mattapallil
Journal:  Clin Vaccine Immunol       Date:  2014-09-03

8.  A comparison of methods for measuring rectal HIV levels suggests that HIV DNA resides in cells other than CD4+ T cells, including myeloid cells.

Authors:  Steven A Yukl; Elizabeth Sinclair; Ma Somsouk; Peter W Hunt; Lorrie Epling; Maudi Killian; Valerie Girling; Peilin Li; Diane V Havlir; Steven G Deeks; Joseph K Wong; Hiroyu Hatano
Journal:  AIDS       Date:  2014-01-28       Impact factor: 4.177

Review 9.  Overcoming pharmacologic sanctuaries.

Authors:  Theodore J Cory; Timothy W Schacker; Mario Stevenson; Courtney V Fletcher
Journal:  Curr Opin HIV AIDS       Date:  2013-05       Impact factor: 4.283

10.  Macrophages sustain HIV replication in vivo independently of T cells.

Authors:  Jenna B Honeycutt; Angela Wahl; Caroline Baker; Rae Ann Spagnuolo; John Foster; Oksana Zakharova; Stephen Wietgrefe; Carolina Caro-Vegas; Victoria Madden; Garrett Sharpe; Ashley T Haase; Joseph J Eron; J Victor Garcia
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.